Therapeutic efficacy of the paradox-breaking panRAF and SRC drug CCT3833/BAL3833 in KRAS-driven cancer models

G. Saturno; F. Lopes; M.R. Girotti; I. Niculescu-Duvaz; D. Niculescu-Duvaz; A. Zambon; L. Davies; L. Johnson; N. Preece; A. Viros; M. Pedersen; R. McLeary; R. Knight; R. Lee; D. Holovanchuk; A. Fusi; P. Lorigan; N. Dhomen; R. Marais; C. Springer

doi:10.1016/s0959-8049(16)61703-3

Therapeutic efficacy of the paradox-breaking panRAF and SRC drug CCT3833/BAL3833 in KRAS-driven cancer models

G. Saturno, F. Lopes, M.R. Girotti, I. Niculescu-Duvaz, D. Niculescu-Duvaz, A. Zambon, L. Davies, L. Johnson, N. Preece, A. Viros, M. Pedersen, R. McLeary, R. Knight, R. Lee, D. Holovanchuk, A. Fusi, P. Lorigan, N. Dhomen, R. Marais, C. Springer

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	S199
Journal	European Journal of Cancer
Volume	61
DOIs	https://doi.org/10.1016/s0959-8049(16)61703-3
Publication status	Published - Jul 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/s0959-8049(16)61703-3

Cite this

Saturno, G., Lopes, F., Girotti, M. R., Niculescu-Duvaz, I., Niculescu-Duvaz, D., Zambon, A., Davies, L., Johnson, L., Preece, N., Viros, A., Pedersen, M., McLeary, R., Knight, R., Lee, R., Holovanchuk, D., Fusi, A., Lorigan, P., Dhomen, N., Marais, R., & Springer, C. (2016). Therapeutic efficacy of the paradox-breaking panRAF and SRC drug CCT3833/BAL3833 in KRAS-driven cancer models. European Journal of Cancer, 61, S199. https://doi.org/10.1016/s0959-8049(16)61703-3

@article{8f457493f1714ba2a5277b62836cc9ac,

title = "Therapeutic efficacy of the paradox-breaking panRAF and SRC drug CCT3833/BAL3833 in KRAS-driven cancer models",

author = "G. Saturno and F. Lopes and M.R. Girotti and I. Niculescu-Duvaz and D. Niculescu-Duvaz and A. Zambon and L. Davies and L. Johnson and N. Preece and A. Viros and M. Pedersen and R. McLeary and R. Knight and R. Lee and D. Holovanchuk and A. Fusi and P. Lorigan and N. Dhomen and R. Marais and C. Springer",

year = "2016",

month = jul,

doi = "10.1016/s0959-8049(16)61703-3",

language = "English",

volume = "61",

pages = "S199",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier BV",

}

Saturno, G, Lopes, F, Girotti, MR, Niculescu-Duvaz, I, Niculescu-Duvaz, D, Zambon, A, Davies, L, Johnson, L, Preece, N, Viros, A, Pedersen, M, McLeary, R, Knight, R, Lee, R, Holovanchuk, D, Fusi, A, Lorigan, P, Dhomen, N, Marais, R & Springer, C 2016, 'Therapeutic efficacy of the paradox-breaking panRAF and SRC drug CCT3833/BAL3833 in KRAS-driven cancer models', European Journal of Cancer, vol. 61, pp. S199. https://doi.org/10.1016/s0959-8049(16)61703-3

TY - JOUR

T1 - Therapeutic efficacy of the paradox-breaking panRAF and SRC drug CCT3833/BAL3833 in KRAS-driven cancer models

AU - Saturno, G.

AU - Lopes, F.

AU - Girotti, M.R.

AU - Niculescu-Duvaz, I.

AU - Niculescu-Duvaz, D.

AU - Zambon, A.

AU - Davies, L.

AU - Johnson, L.

AU - Preece, N.

AU - Viros, A.

AU - Pedersen, M.

AU - McLeary, R.

AU - Knight, R.

AU - Lee, R.

AU - Holovanchuk, D.

AU - Fusi, A.

AU - Lorigan, P.

AU - Dhomen, N.

AU - Marais, R.

AU - Springer, C.

PY - 2016/7

Y1 - 2016/7

UR - http://www.mendeley.com/research/therapeutic-efficacy-paradoxbreaking-panraf-src-drug-cct3833bal3833-krasdriven-cancer-models

U2 - 10.1016/s0959-8049(16)61703-3

DO - 10.1016/s0959-8049(16)61703-3

M3 - Article

SN - 0959-8049

VL - 61

SP - S199

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

Therapeutic efficacy of the paradox-breaking panRAF and SRC drug CCT3833/BAL3833 in KRAS-driven cancer models

UN SDGs

Access to Document

Other files and links

Cite this